A federal deadline is approaching for companies working with a specific form of engineered nanomaterial, following regulatory action taken by the Environmental Protection Agency earlier this month. The EPA’s new rules governing
Artificial intelligence in mergers and acquisitions is no longer simply a productivity tool but a core component of how deals are structured and executed. The shift extends well beyond faster document review,
More
Roberts recently penned a lengthy tribute to William Howard Taft, one that observers say reflects as much on Roberts’ own judicial record as on Taft’s historical contributions. Taft remains a unique figure
More
The FTSE 100 reversed early losses to close in positive territory on Wednesday after the US Treasury announced plans to significantly increase buybacks of longer-dated bonds. The blue-chip index ended the session
More
Ithaca Energy and Oxford Nanopore Technologies delivered standout performances among FTSE 250 constituents during a notably positive session for mid-cap stocks. Ithaca Energy, the North Sea-focused oil and gas producer, has been
More
Regeneron Pharmaceuticals (REGN) has secured a landmark FDA approval for its monoclonal antibody garetosmab, now commercially known as Pasatru, after more than ten years in development. The drug becomes the second FDA-cleared
More
The U.S. Citizenship and Immigration Services has issued an interim final rule establishing a framework for requiring certain immigration benefit requests to be filed electronically. The rule, published on August 11, 2026,
More
The Justice Department has filed its opposition to James Comey’s motions to dismiss the so-called seashell case, submitting its most detailed defense of the indictment yet. The federal government is prosecuting the
More
Ithaca Energy (LSE: ITH) is drawing serious attention from income investors thanks to a dividend forecast that comfortably outpaces the wider FTSE 100 average yield of 3.03%. The company is one of
More
Harbour Energy (HBR) is targeting a shareholder return of 15% in 2026, driven by what the company describes as bumper cash flows from its operations. The North Sea-focused oil and gas producer
More
Pharmacovigilance is undergoing a fundamental shift as artificial intelligence transforms how pharmaceutical companies detect, monitor, and respond to drug safety signals. Writing for Pharmaceutical Commerce, Updesh Dosanjh of IQVIA argues that AI-powered
More